Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. blood cell
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Blood Cell Articles & Analysis

123 news found

Ace Therapeutics Releases BBBporter™ Technology Platform to Overcome the Challenges of Brain Drug Delivery

Ace Therapeutics Releases BBBporter™ Technology Platform to Overcome the Challenges of Brain Drug Delivery

Once the targeting vector and its drug load bind to receptors on the blood side of brain endothelial cells, the vector-load complex is rapidly endocytosed and subsequently undergoes intracellular/intercellular transport. This ultimately results in the entry of the load into the cells and its passage across the blood-brain barrier ...

ByAce Therapeutics


Neutrophils and Lactoferrin a key duo in inflammation

Neutrophils and Lactoferrin a key duo in inflammation

Neutrophils are the most abundant white blood cells in the human body and among the very first immune cells to be recruited during inflammation. ...

ByBertin Technologies


Hemostemix’s Social Media for Investors and Florida’s No-Option Patients

Hemostemix’s Social Media for Investors and Florida’s No-Option Patients

Hemostemix Inc. (TSX-V: HEM; OTCQB: HMTXF; FSE: 2VF0), the leading autologous (patient’s own) stem cell therapy company offering treatments for no-option patients in Florida suffering from Chronic Limb Threatening Ischemia, Peripheral Arterial Disease, Angina, Ischemic Cardiomyopathy, non Ischemic Dilated Cardiomyopathy, and Congestive Heart Failure, is pleased to announce additions to ...

ByHemostemix Inc.


Cells: Hemostemix ACP-01 and NCP-01 Provides the Scientific Basis for Improving the Longevity and Signal Uptake of Brain Computer Implants

Cells: Hemostemix ACP-01 and NCP-01 Provides the Scientific Basis for Improving the Longevity and Signal Uptake of Brain Computer Implants

Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company“) is excited to highlight a groundbreaking research article published in Cells on June?29,?2025, by Dr. Fraser C. Henderson Sr. and Ms. Kelly?Tuchman, exploring how a combination of the patient’s own ACP-01 and NCP-01 (autologous blood-derived ...

ByHemostemix Inc.


The Effect of Combined Exercise and Diet on Obese Mice

The Effect of Combined Exercise and Diet on Obese Mice

Obesity is a metabolic condition resulting from an imbalance between the energy consumed and the energy expended. This is often caused by an increase in the intake of calorie-dense foods and a decrease in physical activity, leading to an abnormal build-up of fat. Such fat accumulation can have serious health consequences, raising the risk of chronic diseases like cardiovascular conditions, ...

BySCIREQ - an emka TECHNOLOGIES Company


Tethis S.p.A. Collaborates with Weill Cornell Medicine to Advance Cellular Residual Disease Monitoring in Early-Stage Breast Cancer

Tethis S.p.A. Collaborates with Weill Cornell Medicine to Advance Cellular Residual Disease Monitoring in Early-Stage Breast Cancer

As part of the collaboration, Tethis has placed one of its automated See.d instruments in the Cristofanilli lab, and the lab will use the instrument to isolate plasma and prepare cytology slides containing cells, including circulating tumor cells, from the blood. The Cristofanilli lab will analyze the isolated plasma samples for ...

ByTethis S.p.A


CD BioGlyco Now Provides Comprehensive Lectin Products for Glycobiology Research

CD BioGlyco Now Provides Comprehensive Lectin Products for Glycobiology Research

It is named lectin because it can agglutinate red blood cells (including blood group substances). Commonly used is Phytoagglutin (PNA), which is usually named after the plant from which it is extracted, such as Conconvalina (ConA), Wheat germ agglutinin (WGA), Peanut agglutinin (Peanut agglutinin, PNA) and soybean lectin (Soybean agglutinin, ...

ByCD BioGlyco.


FPI Explores the Future of Cognitive Healthcare at the 87th China International Medical Equipment Fair (CMEF)

FPI Explores the Future of Cognitive Healthcare at the 87th China International Medical Equipment Fair (CMEF)

It is crucial for the identification of novel biomarkers, the diagnosis of diseases such as Alzheimer's, and the biological analysis of drug development processes.POWCLIN, a subsidiary of FPI's Life Sciences division, has developed its own cell analysis-focused SFLO series of full-spectrum flow cytometers and MSFLO benchtop mass spectrometry flow cytometers. The SFLO series is ...

ByFocused Photonics Inc. (FPI)


Atelerix presents promising data for the application of its technology LeukoStor™ to Monocyte Preservation

Atelerix presents promising data for the application of its technology LeukoStor™ to Monocyte Preservation

Peripheral blood mononuclear cells (PBMCs), derived from whole blood or leukapheresis, encompass several major immune cell populations including lymphocytes, monocytes, NK cells and dendritic cells. Apheresis material is a PBMC-enriched blood product widely used in ...

ByAtelerix Ltd


Circulating Tumor Cell detection by Menarini Group’s CELLSEARCH System leading to genomic profiling of myeloma cells shows potential for non-invasive management of Multiple Myeloma patients at early stages of disease

Circulating Tumor Cell detection by Menarini Group’s CELLSEARCH System leading to genomic profiling of myeloma cells shows potential for non-invasive management of Multiple Myeloma patients at early stages of disease

MM accounts for 10% of hematological malignancies and has a current worldwide incidence level of 160,0002. This type of blood cancer forms in plasma cells (PCs) located in the bone marrow (BM). ...

ByThe Menarini Group


MorphoSys AG: MorphoSys Expects Topline Data from Phase 3 Study of Pelabresib in Myelofibrosis in Early 2024

MorphoSys AG: MorphoSys Expects Topline Data from Phase 3 Study of Pelabresib in Myelofibrosis in Early 2024

About Myelofibrosis Myelofibrosis is a type of bone marrow cancer that causes extensive scarring in the bone marrow, which disrupts the body’s normal production of healthy blood cells. The result is a reduction in red blood cells, which can cause weakness and fatigue, and in platelets, which increases the risk of bleeding ...

ByMorphoSys AG


MorphoSys Presents New Longer-term Phase 2 Results on Pelabresib in Myelofibrosis, Including Potential Disease-Modifying Activity, at ASH 2022

MorphoSys Presents New Longer-term Phase 2 Results on Pelabresib in Myelofibrosis, Including Potential Disease-Modifying Activity, at ASH 2022

About Myelofibrosis Myelofibrosis is a type of bone marrow cancer that causes extensive scarring in the bone marrow, which disrupts the body’s normal production of healthy blood cells. The result is a reduction in red blood cells, which can cause weakness and fatigue, and in platelets, which increases the risk of bleeding ...

ByMorphoSys AG


Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop Autologous CAR-T Cell Therapy for Cutaneous T-Cell Lymphoma

Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop Autologous CAR-T Cell Therapy for Cutaneous T-Cell Lymphoma

In addition to their outstanding clinical research in oncology, Peter Mac through Cell Therapies Pty Ltd has substantial experience in manufacturing of cell therapies for ...

ByCartherics Pty ltd


Rarecells, Inc. announces successful Series A funding, reaching $13 Million raised to develop Liquid Biopsy Early Cancer Detection Tests

Rarecells, Inc. announces successful Series A funding, reaching $13 Million raised to develop Liquid Biopsy Early Cancer Detection Tests

Rarecells leverages its proprietary ISET® Circulating Tumor Cells (CTC) platform, combined with cutting-edge downstream analyses, to generate a novel and powerful approach to detect evidence of a tumor from a blood sample. ...

ByRarecells Diagnostics SAS


ISET technology applied to DLA products from NSCLC patients identified more CTC than other systems

ISET technology applied to DLA products from NSCLC patients identified more CTC than other systems

Antibody-based systems are known to underperform for isolating Circulating Tumor Cells (CTC) due to low or lack of markers expression in critical subsets of CTC. The marker-independent ISET technology has already been shown to detect CTC from NSCLC with unparalleled sensitivity and specificity, prior to imaging. However, CTC rarity in usual blood draw volumes ...

ByRarecells Diagnostics SAS


Rarecells, Inc. to fund a clinical study at Columbia University of its ISET® -AML test for early detection of Acute Myeloid Leukemia (AML)

Rarecells, Inc. to fund a clinical study at Columbia University of its ISET® -AML test for early detection of Acute Myeloid Leukemia (AML)

Currently, patients with MDS are monitored with blood tests to measure complete blood cell counts and bone marrow analyses to detect the appearance of leukemic blasts heralding the development of AML. ...

ByRarecells Diagnostics SAS


Immune-Onc Therapeutics Enters into Clinical Collaboration with BeiGene in China

Immune-Onc Therapeutics Enters into Clinical Collaboration with BeiGene in China

It blocks the interaction of LILRB4 with multiple ligands, including ApoE and Fibronectin, and has broad potential as an immunotherapy in both blood cancers and solid tumors. In hematologic malignancies, preclinical studies showed that IO-202 converts a “don’t kill me” to a “kill me” signal by activating T cell killing and converts a ...

ByImmune-Onc Therapeutics, Inc.


Expert Panel Calls for Use of Blood Volume Measurement to Assess Heart Failure Patients at Key Scientific Meeting

Expert Panel Calls for Use of Blood Volume Measurement to Assess Heart Failure Patients at Key Scientific Meeting

Miller also highlighted the importance of knowing the red blood cell volume to optimize fluid management which is a key metric of Daxor’s BVA-100 blood test, which he has utilized to publish more than a dozen peer-reviewed papers in leading journals. ...

ByDaxor Corporation


BillionToOne Launches Novel Fetal Antigen NIPT as Part of UNITY Screen

BillionToOne Launches Novel Fetal Antigen NIPT as Part of UNITY Screen

For pregnant patients who are alloimmunized with C, c, D, E, Duffy (Fya), or Kell (K) red blood cell (RBC) antibodies, this novel NIPT looks for the presence of the genetic variants that code for the corresponding fetal antigens. ...

ByBillionToOne Inc.


CO2 laser treatment for acne scars

CO2 laser treatment for acne scars

The scars left by acne are directly related to blood heat and dampness toxin. The accumulation of blood toxins in the body, the decline in the blood’s ability to carry and supply oxygen, and the poor blood microcirculation make skin cells unable to obtain the oxygen and nutrients required for normal ...

ByBvlaser Bestview Medical and Beauty Equipment Co., Ltd

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT